表紙
市場調査レポート

世界のインスリンポンプ市場:パイプライン分析、競争環境、2017年までの市場予測

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

発行 GlobalData 商品コード 224429
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界のインスリンポンプ市場:パイプライン分析、競争環境、2017年までの市場予測 Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
出版日: 2011年12月05日 ページ情報: 英文 88 Pages
概要

当レポートでは、インスリンポンプの世界市場の最新動向と将来展望について分析し、全体的な市場構造、全世界の市場動向(2003〜2017年の市場収益の計測・予測など)、部門別・国別の市場動向、主要企業のプロファイル、開発中の製品のパイプライン評価などの情報を取りまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション・概要

第3章 疾患の概要:糖尿病

  • 糖尿病の種類
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠性糖尿病
  • 兆候
  • 診断
    • 空腹時血糖値(FPG)検査
    • 経口ブドウ糖負荷試験(OGTT)
    • ランダム血漿グルコース試験
  • 疫学
    • 米国での糖尿業の疫学
    • 英国での糖尿業の疫学
    • 日本での糖尿業の疫学
    • インドでの糖尿業の疫学
    • 中国での糖尿業の疫学

第4章 インスリンポンプ:装置の概要

  • 市場の分類
    • 従来型インスリンポンプ
    • 使い捨て型インスリンポンプ
  • インスリンポンプと他のインスリン投与装置との比較

第5章 世界のインスリン市場の特徴

  • 市場収益実績値(全世界、2003〜2010年)
  • 市場収益予測値(全世界、2010〜2017年)
  • 世界のインスリンポンプ市場の主な傾向
    • 米国では欧州よりもインスリンポンプの市場普及率が高い
    • FDA(米国食品薬品局)は注入ポンプの規制を強化する見込み
    • インスリンポンプと血糖値モニタリング/継続的グルコース監視装置の共同マーケティングが、昨今の市場傾向である
    • 人工膵臓が今後のインスリンポンプ市場の傾向となる
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第6章 部門別の分析

  • 従来型インスリンポンプ:市場収益実績値(全世界、2003〜2010年)
  • 従来型インスリンポンプ:市場収益予測値(全世界、2010〜2017年)
    • 市場促進要因
    • 市場抑制要因
  • 使い捨て型インスリンポンプ:市場収益実績値(全世界、2003〜2010年)
  • 使い捨て型インスリンポンプ:市場収益予測値(全世界、2010〜2017年)
    • 市場促進要因
    • 市場抑制要因

第7章 国別の分析・予測

  • 市場収益実績値(米国、2003〜2010年)
  • 市場収益予測値(米国、2010〜2017年)
  • 市場収益実績値(カナダ、2003〜2010年)
  • 市場収益予測値(カナダ、2010〜2017年)
  • 市場収益実績値(英国、2003〜2010年)
  • 市場収益予測値(英国、2010〜2017年)
  • 市場収益実績値(ドイツ、2003〜2010年)
  • 市場収益予測値(ドイツ、2010〜2017年)
  • 市場収益実績値(フランス、2003〜2010年)
  • 市場収益予測値(フランス、2010〜2017年)
  • 市場収益実績値(イタリア、2003〜2010年)
  • 市場収益予測値(イタリア、2010〜2017年)
  • 市場収益実績値(スペイン、2003〜2010年)
  • 市場収益予測値(スペイン、2010〜2017年)
  • 市場収益実績値(日本、2003〜2010年)
  • 市場収益予測値(日本、2010〜2017年)
  • 市場収益実績値(中国、2003〜2010年)
  • 市場収益予測値(中国、2010〜2017年)
  • 市場収益実績値(インド、2003〜2010年)
  • 市場収益予測値(インド、2010〜2017年)
  • 市場収益実績値(オーストラリア、2003〜2010年)
  • 市場収益予測値(オーストラリア、2010〜2017年)
  • 市場収益実績値(ブラジル、2003〜2010年)
  • 市場収益予測値(ブラジル、2010〜2017年)

第8章 競争企業評価

  • 主要企業の市場シェア(全世界、2010年)
  • 主な企業(全世界)
    • Medtronic Inc.
    • Insulet Corporation
    • Roche (Disetronic Medical Systems AG)
    • Animas Corporation

第9章 パイプライン評価

  • インスリンポンプのパイプライン:開発フェーズ別(2011年)
  • パイプライン評価:開発段階別(2011年)
  • 主なパイプライン製品
    • Artificial Pancreas System (Boston University)
    • Artificial Pancreas System (University of Virginia)
    • Cellnovo Wireless Insulin Pump System (Cellnovo Ltd.)
    • Eros Insulin Pump (Insulet Corporation)
    • Jewel Pump (Debiotech S.A.)
    • Minimed Model 2007 Implantable Insulin Pump (Medtronic, Inc.)
    • Paradigm Veo System (Medtronic, Inc.)
    • Solo MicroPump Insulin Delivery System (Roche Diagnostics GmbH)

第10章 戦略的取引分析

  • インスリンポンプ市場での主な資本取引

第11章 付録

図表一覧

目次

Summary

GlobalData's new report, "Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include Disposable Insulin Pumps and Traditional Insulin Pumps.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the insulin pumps market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Animas Corporation and Insulet Corporation.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the insulin pumps globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the insulin pumps market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global insulin pumps market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction and Overview

  • 2.1. Introduction
  • 2.2. GlobalData Report Guidance

3. Disease Overview - Diabetes

  • 3.1. Types of Diabetes
    • 3.1.1. Type 1 diabetes
    • 3.1.2. Type 2 diabetes
    • 3.1.3. Gestational diabetes
  • 3.2. Signs and Symptoms
  • 3.3. Diagnosis
    • 3.3.1. Fasting Plasma Glucose (FPG) Test
    • 3.3.2. Oral Glucose Tolerance Test (OGTT)
    • 3.3.3. Random Plasma Glucose Test
  • 3.4. Epidemiology
    • 3.4.1. Epidemiology of Diabetes in the US
    • 3.4.2. Epidemiology of Diabetes in UK
    • 3.4.3. Epidemiology of Diabetes in Japan
    • 3.4.4. Epidemiology of Diabetes in India
    • 3.4.5. Epidemiology of Diabetes in China

4. Insulin Pumps - Device Overview

  • 4.1. Insulin Pumps, Market Segmentation
    • 4.1.1. Traditional Insulin Pumps
    • 4.1.2. Disposable Insulin Pumps
  • 4.2. Comparison of Insulin Pumps with Other Insulin Delivery Devices

5. Insulin Pumps - Global Market Characterization

  • 5.1. Insulin Pumps Market, Global, Revenue ($m), Historic, 2003-2010
  • 5.2. Insulin Pumps Market, Global, Revenue ($m), Forecast, 2010-2017
  • 5.3. Global Insulin Pumps Market, Key Trends
    • 5.3.1. The US has a Higher Market Penetration Rate for Insulin Pumps Compared to Europe
    • 5.3.2. FDA Plans to Tighten the Regulation of Infusion Pumps
    • 5.3.3. Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Trend in the Market
    • 5.3.4. Artificial Pancreas to be a Future Trend in the Insulin Pumps Market
  • 5.4. Global Insulin Pumps, Market Dynamics
    • 5.4.1. Market Drivers
    • 5.4.2. Market Restraints

6. Global Insulin Pumps Market - Analysis by Segment

  • 6.1. Traditional Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010
  • 6.2. Traditional Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017
    • 6.2.1. Market Drivers
    • 6.2.2. Market Restraints
  • 6.3. Disposable Insulin Pumps, Global, Revenue ($m), Historic, 2005-2010
  • 6.4. Disposable Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017
    • 6.4.1. Market Drivers
    • 6.4.2. Market Restraints

7. Global Insulin Pumps Market - Analysis and Forecasts by Country

  • 7.1. Insulin Pumps Market, The US, Revenue ($m), Historic, 2003-2010
  • 7.2. Insulin Pumps Market, The US, Revenue ($m), Forecast, 2010-2017
  • 7.3. Insulin Pumps Market, Canada, Revenue ($m), Historic, 2003-2010
  • 7.4. Insulin Pumps Market, Canada, Revenue ($m), Forecast, 2010-2017
  • 7.5. Insulin Pumps Market, The UK, Revenue ($m), Historic, 2003-2010
  • 7.6. Insulin Pumps Market, The UK, Revenue ($m), Forecast, 2010-2017
  • 7.7. Insulin Pumps Market, Germany, Revenue ($m), Historic, 2003-2010
  • 7.8. Insulin Pumps Market, Germany, Revenue ($m), Forecast, 2010-2017
  • 7.9. Insulin Pumps Market, France, Revenue ($m), Historic, 2003-2010
  • 7.10. Insulin Pumps Market, France, Revenue ($m), Forecast, 2010-2017
  • 7.11. Insulin Pumps Market, Italy, Revenue ($m), Historic, 2003-2010
  • 7.12. Insulin Pumps Market, Italy, Revenue ($m), Forecast, 2010-2017
  • 7.13. Insulin Pumps Market, Spain, Revenue ($m), Historic, 2003-2010
  • 7.14. Insulin Pumps Market, Spain, Revenue ($m), Forecast, 2010-2017
  • 7.15. Insulin Pumps Market, Japan, Revenue ($m), Historic, 2003-2010
  • 7.16. Insulin Pumps Market, Japan, Revenue ($m), Forecast, 2010-2017
  • 7.17. Insulin Pumps Market, China, Revenue ($m), Historic, 2003-2010
  • 7.18. Insulin Pumps Market, China, Revenue ($m), Forecast, 2010-2017
  • 7.19. Insulin Pumps Market, India, Revenue ($m), Historic, 2003-2010
  • 7.20. Insulin Pumps Market, India, Revenue ($m), Forecast, 2010-2017
  • 7.21. Insulin Pumps Market, Australia, Revenue ($m), Historic, 2003-2010
  • 7.22. Insulin Pumps Market, Australia, Revenue ($m), Forecast, 2010-2017
  • 7.23. Insulin Pumps Market, Brazil, Revenue ($m), Historic, 2003-2010
  • 7.24. Insulin Pumps Market, Brazil, Revenue ($m), Forecast, 2010-2017

8. Global Insulin Pumps Market - Competitive Assessment

  • 8.1. Insulin Pumps Market, Global, Key Company Shares (%), 2010
  • 8.2. Insulin Pumps Market, Global, Key Market Participants
    • 8.2.1. Medtronic Inc.
    • 8.2.2. Insulet Corporation
    • 8.2.3. Roche (Disetronic Medical Systems AG)
    • 8.2.4. Animas Corporation

9. Insulin Pumps - Pipeline Assessment

  • 9.1. Insulin Pumps, Pipeline by Phase of Development, 2011
  • 9.2. Pipeline Assessment by Developmental Stage, 2011
  • 9.3. Key Pipeline Products
    • 9.3.1. Artificial Pancreas System (Boston University)
    • 9.3.2. Artificial Pancreas System (University of Virginia)
    • 9.3.3. Cellnovo Wireless Insulin Pump System (Cellnovo Ltd.)
    • 9.3.4. Eros Insulin Pump (Insulet Corporation)
    • 9.3.5. Jewel Pump (Debiotech S.A.)
    • 9.3.6. Minimed Model 2007 Implantable Insulin Pump (Medtronic, Inc.)
    • 9.3.7. Paradigm Veo System (Medtronic, Inc.)
    • 9.3.8. Solo MicroPump Insulin Delivery System (Roche Diagnostics GmbH)

10. Global Insulin Pumps Market - Strategic Deals Analysis

  • 10.1. Key Deals, Insulin Pumps Market
    • 10.1.1. Cellnovo Enters Into Technology Integration Agreement with LifeScan
    • 10.1.2. Insulet Announced Acquisition of Neighborhood Diabetes
    • 10.1.3. Insulet Entered into Distribution Agreement with GlaxoSmithKline
    • 10.1.4. Cellnovo Entered into an Agreement with Home Diagnostics
    • 10.1.5. Roche Holding Acquired Medingo from Elron Electronic Industries
    • 10.1.6. JDRF Enters into an Agreement with Becton, Dickinson and Company
    • 10.1.7. Insulet Enters into Distribution Agreement with Ypsomed Holding

11. Appendix

  • 11.1. Market Definitions
    • 11.1.1. Insulin Pumps
  • 11.2. Abbreviations (in alphabetical order)
  • 11.3. Sources
  • 11.4. Research Methodology
  • 11.5. GlobalData Consulting
  • 11.6. Contact Us
  • 11.7. Disclaimer

List of Tables

  • Table 1: Fasting Plasma Glucose Test
  • Table 2: Oral Glucose Tolerance Test
  • Table 3: Oral Glucose Tolerance Test for Gestational Diabetes
  • Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011
  • Table 5: Insulin Pumps Market, Global, Revenue ($m), 2003-2010
  • Table 6: Insulin Pumps Market, Global, Revenue ($m), 2010-2017
  • Table 7: Organizations/Companies Developing Artificial Pancreas
  • Table 8: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005
  • Table 9: Studies Indicating Safety and Efficacy of Insulin Pumps
  • Table 10: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011
  • Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 & 2009
  • Table 12: Traditional Insulin Pumps, Global, Revenue ($m), 2003-2010
  • Table 13: Traditional Insulin Pumps, Global, Revenue ($m), 2010-2017
  • Table 14: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income <$15000, June 2011
  • Table 15: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011
  • Table 16: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011
  • Table 17: Disposable Insulin Pumps, Global, Revenue ($m), 2005-2010
  • Table 18: Disposable Insulin Pumps, Global, Revenue ($m), 2010-2017
  • Table 19: Insulin Pumps Market, The US, Revenue ($m), 2003-2010
  • Table 20: Insulin Pumps Market, The US, Revenue ($m), 2010-2017
  • Table 21: Insulin Pumps Market, Canada, Revenue ($m), 2003-2010
  • Table 22: Insulin Pumps Market, Canada, Revenue ($m), 2010-2017
  • Table 23: Insulin Pumps Market, The UK, Revenue ($m), 2003-2010
  • Table 24: Insulin Pumps Market, The UK, Revenue ($m), 2010-2017
  • Table 25: Insulin Pumps Market, Germany, Revenue ($m), 2003-2010
  • Table 26: Insulin Pumps Market, Germany, Revenue ($m), 2010-2017
  • Table 27: Insulin Pumps Market, France, Revenue ($m), 2003-2010
  • Table 28: Insulin Pumps Market, France, Revenue ($m), 2010-2017
  • Table 29: Insulin Pumps Market, Italy, Revenue ($m), 2003-2010
  • Table 30: Insulin Pumps Market, Italy, Revenue ($m), 2010-2017
  • Table 31: Insulin Pumps Market, Spain, Revenue ($m), 2003-2010
  • Table 32: Insulin Pumps Market, Spain, Revenue ($m), 2010-2017
  • Table 33: Insulin Pumps Market, Japan, Revenue ($m), 2003-2010
  • Table 34: Insulin Pumps Market, Japan, Revenue ($m), 2010-2017
  • Table 35: Insulin Pumps Market, China, Revenue ($m), 2003-2010
  • Table 36: Insulin Pumps Market, China, Revenue ($m), 2010-2017
  • Table 37: Insulin Pumps Market, India, Revenue ($m), 2003-2010
  • Table 38: Insulin Pumps Market, India, Revenue ($m), 2010-2017
  • Table 39: Insulin Pumps Market, Australia, Revenue ($m), 2003-2010
  • Table 40: Insulin Pumps Market, Australia, Revenue ($m), 2010-2017
  • Table 41: Insulin Pumps Market, Brazil, Revenue ($m), 2003-2010
  • Table 42: Insulin Pumps Market, Brazil, Revenue ($m), 2010-2017
  • Table 43: Insulin Pumps Market, Global, Key Company Revenues ($m), 2010
  • Table 44: Pipeline Products, Medtronic Inc.
  • Table 45: Key Products, Medtronic Inc.
  • Table 46: Key Products, Insulet Corporation
  • Table 47: Key Products, Disetronic Medical Systems AG
  • Table 48: Pipeline Products, Animas Corporation
  • Table 49: Key Products, Animas Corporation
  • Table 50: Insulin Pumps, Pipeline by Phase of Development, 2011
  • Table 51: Pipeline Products, Insulin Pumps
  • Table 52: Artificial Pancreas System (Boston University), Clinical Trial Details
  • Table 53: Artificial Pancreas System (University of Virginia), Clinical Trial Details
  • Table 54: Key Deals, Insulin Pumps Market, 2009-2011

List of Figures

  • Figure 1: Diabetes Prevalence (%), Global, 2011
  • Figure 2: Insulin Pumps, Market Segmentation
  • Figure 3: Comparison of Insulin Pumps with Other Insulin Delivery Devices
  • Figure 4: Insulin Pumps Market, Global, Revenue ($m), 2003-2010
  • Figure 5: Insulin Pumps Market, Global, Revenue ($m), 2010-2017
  • Figure 6: Working of Artificial Pancreas
  • Figure 7: Global Insulin Pumps, Market Dynamics
  • Figure 8: Reasons for Type 1 Diabetes in Children
  • Figure 9: Traditional Insulin Pumps, Global, Revenue ($m), 2003-2010
  • Figure 10: Traditional Insulin Pumps, Global, Revenue ($m), 2010-2017
  • Figure 11: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income <$15,000, June 2011
  • Figure 12: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011
  • Figure 13: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011
  • Figure 14: Disposable Insulin Pumps, Global, Revenue ($m), 2005-2010
  • Figure 15: Disposable Insulin Pumps, Global, Revenue ($m), 2010-2017
  • Figure 16: Insulin Pumps Market, The US, Revenue ($m), 2003-2010
  • Figure 17: Insulin Pumps Market, The US, Revenue ($m), 2010-2017
  • Figure 18: Insulin Pumps Market, Canada, Revenue ($m), 2003-2010
  • Figure 19: Insulin Pumps Market, Canada, Revenue ($m), 2010-2017
  • Figure 20: Insulin Pumps Market, The UK, Revenue ($m), 2003-2010
  • Figure 21: Insulin Pumps Market, The UK, Revenue ($m), 2010-2017
  • Figure 22: Insulin Pumps Market, Germany, Revenue ($m), 2003-2010
  • Figure 23: Insulin Pumps Market, Germany, Revenue ($m), 2010-2017
  • Figure 24: Insulin Pumps Market, France, Revenue ($m), 2003-2010
  • Figure 25: Insulin Pumps Market, France, Revenue ($m), 2010-2017
  • Figure 26: Insulin Pumps Market, Italy, Revenue ($m), 2003-2010
  • Figure 27: Insulin Pumps Market, Italy, Revenue ($m), 2010-2017
  • Figure 28: Insulin Pumps Market, Spain, Revenue ($m), 2003-2010
  • Figure 29: Insulin Pumps Market, Spain, Revenue ($m), 2010-2017
  • Figure 30: Insulin Pumps Market, Japan, Revenue ($m), 2003-2010
  • Figure 31: Insulin Pumps Market, Japan, Revenue ($m), 2010-2017
  • Figure 32: Insulin Pumps Market, China, Revenue ($m), 2003-2010
  • Figure 33: Insulin Pumps Market, China, Revenue ($m), 2010-2017
  • Figure 34: Insulin Pumps Market, India, Revenue ($m), 2003-2010
  • Figure 35: Insulin Pumps Market, India, Revenue ($m), 2010-2017
  • Figure 36: Insulin Pumps Market, Australia, Revenue ($m), 2003-2010
  • Figure 37: Insulin Pumps Market, Australia, Revenue ($m), 2010-2017
  • Figure 38: Insulin Pumps Market, Brazil, Revenue ($m), 2003-2010
  • Figure 39: Insulin Pumps Market, Brazil, Revenue ($m), 2010-2017
  • Figure 40: Insulin Pumps Market, Global, Key Company Shares (%), 2010
  • Figure 41: Insulin Pumps Market, Competitive Assessment
  • Figure 42: Insulin Pumps, Pipeline by Phase of Development, 2011
  • Figure 43: Pipeline Assessment by Developmental Stage, 2011
Back to Top